SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9561	Companies
188860	Keywords
120593	Articles
100791	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 12/19/2025 at 20:26, 2 days 7 hours ago

Sanofi signs an agreement with the United States to reduce the cost of medicines

Biopharmaceutical Innovation Sanofi Affordable Medications Trump Deal Investments In The United States
BRIEF

published on 12/19/2025 at 20:26, 2 days 7 hours ago

Sanofi Agreement with US Government to Lower Medicine Costs

Innovation Healthcare Savings US Government Sanofi Agreement Medicine Costs
PRESS RELEASE

published on 12/19/2025 at 20:21, 2 days 8 hours ago

Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation
Sanofi agrees with US government to lower medicine costs, support innovation, and US manufacturing. Agreement meets President Trump's requests, ensuring affordable access for American patients

Innovation Manufacturing Sanofi US Government Medicine Costs
BRIEF

published on 12/17/2025 at 07:35, 4 days 20 hours ago

Sanofi publishes the document "Q4 2025 Quick Reference Guide"

Financial Results Investors Sanofi Q4 2025 Modeling
BRIEF

published on 12/17/2025 at 07:35, 4 days 20 hours ago

Sanofi Releases Q4 2025 Aide Mémoire

Sanofi Financial Modeling Aide Mémoire Q4 2025 Forward-Looking
PRESS RELEASE

published on 12/17/2025 at 07:30, 4 days 20 hours ago

Press release: Availability of the Q4 2025 Aide memoire
Sanofi announces availability of Q4 2025 Aide memoire on the company's website for financial modeling purposes. Q4 2025 results to be published on January 29, 2026

Sanofi Results Aide Mémoire Financial Modelling Q4 2025
BRIEF

published on 12/15/2025 at 07:10, 6 days 21 hours ago

Sanofi: PERSEUS study results on tolebrutinib disappointing

Study Results Multiple Sclerosis Sanofi Tolebrutinib PERSEUS Study
BRIEF

published on 12/15/2025 at 07:10, 6 days 21 hours ago

Sanofi Halts Pursuit of Regulatory Registration for Tolebrutinib in PPMS

Multiple Sclerosis Tolebrutinib PPMS Trial PERSEUS Study Sanofi R&D
BRIEF

published on 12/15/2025 at 07:05, 6 days 21 hours ago

Sanofi's Tolebrutinib Regulatory Submission Delayed

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Delay
PRESS RELEASE

published on 12/15/2025 at 07:05, 6 days 21 hours ago

Press Release: Sanofi provides update on tolebrutinib in primary progressive multiple sclerosis
Sanofi updates on tolebrutinib in primary progressive multiple sclerosis, PERSEUS phase 3 study did not meet primary endpoint. Safety profile consistent. Financial impacts discussed

Sanofi Tolebrutinib Primary Progressive Multiple Sclerosis PERSEUS Phase 3 Study Financial Considerations

Accesswire

Published on 12/20/2025 at 00:30, 2 days 3 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 6 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 9 hours ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 13 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 2 days 14 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 00:35, 3 hours 49 minutes ago

Samsung to Host Series of Tech Forums at CES 2026
Published on 12/22/2025 at 00:05, 4 hours 19 minutes ago

Samsung To Unveil AI Vision Built With Google Gemini at CES 2026
Published on 12/21/2025 at 08:55, 19 hours 29 minutes ago

Vantage Markets recognised for real-time threat intelligence collaboration with Trend Micro
Published on 12/20/2025 at 16:45, 1 day 11 hours ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 1 day 18 hours ago

FITUR 2026 highlights the strong synergies between Germany and Spain

Les Echos

Published on 12/19/2025 at 08:30, 2 days 19 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 07:00, 2 days 21 hours ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
Published on 12/18/2025 at 18:30, 3 days 9 hours ago

Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV
Published on 12/18/2025 at 17:45, 3 days 10 hours ago

Cie du Bois Sauvage : Cancellation of own shares
Published on 12/18/2025 at 16:31, 3 days 11 hours ago

In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide

View all LES ECHOS COMFI WIRE